David Krause, PhD
Office of Surgical & Infection Control Devices
Office of Product Evaluation & Quality
Center for Devices and Radiological Health
U.S. Food and Drug Administration
Presentation: The FDA Regulatory History of Breast Implants
David Krause, Ph.D., is currently the Deputy Director of the Office of Surgical and Infection Control Devices, also known as the Office of Health Technologies 4 (OHT4) within CDRH’s Office of Product Evaluation and Quality (OPEQ). Dr. Krause earned an M.A. in Biochemistry from Andrews University, in Berrien Springs, Michigan and a Ph.D. in Cellular Biology from the Catholic University of America (CUA) in Washington, DC. After he received his Ph.D. degree, Dr. Krause completed a post-doctoral research fellowship at the Uniformed Services University of the Health Sciences (USUHS) where he studied the mechanism of action of Interferon. After leaving USUHS, Dr. Krause was an Adjunct Assistant Professor and then an Adjunct Associate Professor at CUA, where he studied the interaction of electromagnetic fields with biological systems. Dr. Krause joined FDA/CDRH in 1996 as a device reviewer and later an expert biologist. Dr. Krause was the Branch Chief of the Plastic & Reconstructive Surgery Branch from 2007 until 2014 when he became the Division of Surgical Devices Deputy Director. When CDRH reorganized the Office structure, Dr. Krause became the Deputy Director of the Office of Surgical and Infection Control Devices. Dr. Krause has over 50 published articles, book chapters and abstracts on topics such as acrylamide toxicity, mechanism of action of interferon, electromagnetic interactions with biological systems and device regulatory issues.